ThePharmaTeam ApS Financials, key figures and credit report
Gross profit 11 676.6 kDKK FY 2025 +71.8% vs 2024
EBIT 2 804.6 kDKK FY 2025 +43.8% vs 2024
Net debt -2 624.3 kDKK FY 2025 -14.3% vs 2024
Quick ratio 1.8 FY 2025 +0.1 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -27.78 | 40.80 | 69.64 | 6 795.60 | 11 676.62 |
| Employee benefit expenses | -4 844.97 | -8 872.00 | |||
| EBIT | -27.78 | 40.80 | 69.64 | 1 950.63 | 2 804.62 |
| Other financial income | 0.15 | 43.36 | |||
| Other financial expenses | -0.07 | -2.64 | -0.26 | -2.31 | -19.10 |
| Pre-tax profit | -27.84 | 38.16 | 69.38 | 1 948.47 | 2 828.88 |
| Income taxes | 4.64 | -10.56 | 14.20 | - 465.53 | - 628.74 |
| Net earnings | -23.20 | 27.61 | 83.58 | 1 482.94 | 2 200.14 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Non-current loans receivable | 843.29 | ||||
| Long term receivables total | 843.29 | ||||
| Inventories total | |||||
| Current trade debtors | 962.00 | 865.31 | 2 176.88 | 1 676.00 | 1 353.84 |
| Current other receivables | 47.57 | ||||
| Current deferred tax assets | 4.64 | 31.51 | |||
| Short term receivables total | 966.64 | 865.31 | 2 208.39 | 1 676.00 | 1 401.41 |
| Cash and bank deposits | 482.62 | 1 248.89 | 1 549.89 | 2 295.33 | 2 624.30 |
| Cash and cash equivalents | 482.62 | 1 248.89 | 1 549.89 | 2 295.33 | 2 624.30 |
| Balance sheet total (assets) | 1 449.26 | 2 114.20 | 3 758.28 | 3 971.33 | 4 868.99 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Shares repurchased | 1 200.00 | 1 800.00 | |||
| Retained earnings | -23.20 | 4.41 | -1 112.01 | -1 429.07 | |
| Profit of the financial year | -23.20 | 27.61 | 83.58 | 1 482.94 | 2 200.14 |
| Shareholders equity total | 16.80 | 44.41 | 127.99 | 1 610.93 | 2 611.07 |
| Provisions | 118.95 | ||||
| Non-current liabilities total | |||||
| Current trade creditors | 1 286.20 | 2 040.66 | 3 580.05 | 22.75 | 8.56 |
| Short-term deferred tax liabilities | 5.92 | 17.31 | 434.02 | 328.74 | |
| Other non-interest bearing current liabilities | 27.31 | 23.22 | 32.93 | 1 903.63 | 1 920.63 |
| Current liabilities total | 1 313.51 | 2 069.79 | 3 630.29 | 2 360.40 | 2 257.93 |
| Balance sheet total (liabilities) | 1 449.26 | 2 114.20 | 3 758.28 | 3 971.33 | 4 868.99 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated